The peripheral neuropathy evaluation in an office-based neurology setting

Seminars in Neurology

Volumn 31, Issue 1, 2011, Pages 102-114

  Vavra, Michael W ^a   Rubin, Devon I ^b  

^a Tri State Mountain Neurology Associates   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Neuropathy

Indexed keywords

ALCOHOL; AMITRIPTYLINE; ARSENIC; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CAPSAICIN; CARBAMAZEPINE; CYANOCOBALAMIN; DULOXETINE; GABAPENTIN; GLUCOSE; IMIPRAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LAMOTRIGINE; LIDOCAINE; MERCURY; NORTRIPTYLINE; PHENYTOIN; PREDNISONE; PREGABALIN; PROTON PUMP INHIBITOR; THALLIUM; TOPIRAMATE; TRAMADOL; VITAMIN D;

ACROMEGALY; ACUTE MOTOR AXONAL NEUROPATHY; AMYLOIDOSIS; ANAPHYLAXIS; ANATOMY; ARTICLE; AUTOIMMUNE DISEASE; AVASCULAR NECROSIS; BEDTIME DOSAGE; CARCINOMATOUS MENINGITIS; CARDIOVASCULAR RISK; CATARACT; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY; CLINICAL EVALUATION; CLINICAL EXAMINATION; CRYOGLOBULINEMIA; CYANOCOBALAMIN DEFICIENCY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISTAL SYMMETRIC POLYNEUROPATHY; ELECTRODIAGNOSIS; FABRY DISEASE; FAMILY HISTORY; FOCAL ROOT PLEXUS OR NERVE DISORDER; FOOT MALFORMATION; GAMMOPATHY; GENETIC DISORDER; GENETIC SCREENING; GLAUCOMA; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GUILLAIN BARRE SYNDROME; HEART INFARCTION; HEMATOLOGIC DISEASE; HEPATITIS C; HEREDITARY MOTOR AND SENSORY NEUROPATHY; HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; INFECTION SENSITIVITY; KIDNEY FAILURE; LABORATORY TEST; LEG MUSCLE; LEPROSY; LEWIS SUMMER SYNDROME; LIVER FAILURE; LYME DISEASE; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MONONEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY WITH CONDUCTION BLOCK; MUSCLE ATROPHY; NERVE BIOPSY; NERVE FIBER; NEUROLOGIC EXAMINATION; NEUROLOGY; NEUROPATHIC PAIN; NEUROPATHY; OSTEOPENIA; OSTEOPOROSIS; OSTEOSCLEROTIC MYELOMA; OUTPATIENT DEPARTMENT; PARESTHESIA; PATHOPHYSIOLOGY; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PNEUMOTHORAX; POEMS SYNDROME; POLYARTERITIS NODOSA; PORPHYRIA; PRIORITY JOURNAL; PROPHYLAXIS; RADICULOPATHY; REFLEX DISORDER; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; RISK REDUCTION; SARCOIDOSIS; SCLERODERMA; SENSORY DYSFUNCTION; SIDE EFFECT; SINGLE MONONEUROPATHY; SJOEGREN SYNDROME; SKIN BIOPSY; STROKE; SYMPTOMATOLOGY; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TANGIER DISEASE; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION; WEAKNESS; WEIGHT GAIN;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; HUMANS; NEUROLOGY; OFFICE VISITS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 79951776777     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1271305     Document Type: Article

References (74)

1. England J D., Asbury A K. Peripheral neu (Pubitemid 38844159)
2. Fagius J. Chronic cryptogenic polyneuropathy. The search for a cause. Acta Neurol Scand 1983 67 3 173-180 (Pubitemid 13121066)
3. Prineas J. Polyneuropathies of undetermined cause. Acta Neurol Scand Suppl 1970 44 1-72
4. Smith A G., Singleton J R. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 2004 164 9 1021-1025 (Pubitemid 38581524)
5. Dyck P J., Oviatt K F., Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981 10 3 222-226 (Pubitemid 11014365)
6. Barohn R J. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998 18 1 7-18 (Pubitemid 28166652)
7. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991 41 5 617-618
8. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005 10 3 220-228
9. Haq R U., Fries T J., Pendlebury W W., Kenny M J., Badger G J., Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000 57 12 1745-1750
10. Hughes R, Bensa S, Willison H et al, Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001 50 2 195-201 (Pubitemid 32738144)
11. Nicolas G, Maisonobe T, Le Forestier N, Lger J M., Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002 25 1 26-30 (Pubitemid 34019731)
12. Thaisetthawatkul P, Logigian E L., Herrmann D N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002 59 10 1526-1532 (Pubitemid 35387056)
13. Bromberg M B. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991 14 10 968-976
14. Magda P, Latov N, Brannagan T H. III, Weimer L H., Chin R L., Sander H W. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003 60 12 1755-1759 (Pubitemid 37521632)
15. Molenaar D S., Vermeulen M, de Haan R J. Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol 2002 249 4 400-403 (Pubitemid 34304612)
16. Van den Bergh P Y., Piret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004 29 4 565-574 (Pubitemid 38451348)
17. Jann S, Beretta S, Bramerio M, Defanti C A. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001 24 9 1197-1201 (Pubitemid 32762148)
18. Lubec D, Mllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J 1999 75 890 723-727
19. Wolfe G I., Baker N S., Amato A A. et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 1999 56 5 540-547 (Pubitemid 29218148)
20. Notermans N C., Wokke J H., Franssen H et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993 56 10 1066-1071 (Pubitemid 23304697)
21. Notermans N C., Wokke J H., van der Graaf Y, Franssen H, van Dijk G W., Jennekens F G. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 1994 57 12 1525-1527
22. McLeod J G., Tuck R R., Pollard J D., Cameron J, Walsh J C. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984 47 5 530-535 (Pubitemid 14145504)
23. Johannsen L, Smith T, Havsager A M. et al. Evaluation of patients with symptoms suggestive of chronic polyneuropathy. J Clin Neuromuscul Dis 2001 3 2 47-52 (Pubitemid 33130298)
24. Saperstein D S., Wolfe G I., Gronseth G S. et al. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 2003 60 9 1296-1301 (Pubitemid 37099639)
25. Bednarik J, Vlckova-Moravcova E, Bursova S, Belobradkova J, Dusek L, Sommer C. Etiology of small-fiber neuropathy. J Peripher Nerv Syst 2009 14 3 177-183
26. Sorenson E J., Windebank A J. Hypertriglyceridemia in idiopathic painful small fiber neuropathy. Neurology 2000 54 Suppl 3 A403
27. Singleton J R., Smith A G., Bromberg M B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001 24 8 1448-1453 (Pubitemid 33716436)
28. Hoffman-Snyder C, Smith B E., Ross M A., Hernandez J, Bosch E P. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 2006 63 8 1075-1079 (Pubitemid 44232311)
29. Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adultsUnited States, 1999-2000. MMWR Morb Mortal Wkly Rep 2003 52 35 833-837
30. Novella S P., Inzucchi S E., Goldstein J M. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001 24 9 1229-1231 (Pubitemid 32762153)
31. Gabriel C M., Howard R, Kinsella N et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000 69 4 442-446
32. England J D., Gronseth G S., Franklin G et al, American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009 72 2 177-184
33. Hlubocky A, Wellik K, Ross M A. et al. Skin biopsy for diagnosis of small fiber neuropathy: a critically appraised topic. Neurologist 2010 16 1 61-63
34. Koskinen M, Hietaharju A, Kylniemi M et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 2005 252 7 789-794 (Pubitemid 40984853)
35. Lseth S, Lindal S, Stlberg E, Mellgren S I. Intraepidermal nerve fibre density, quantitative sensory testing and nerve conduction studies in a patient material with symptoms and signs of sensory polyneuropathy. Eur J Neurol 2006 13 2 105-111
36. Shun C T., Chang Y C., Wu H P. et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004 127 Pt 7 1593-1605
37. Sinnreich M, Taylor B V., Dyck P J. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 2005 11 2 63-79 (Pubitemid 40388430)
38. Dyck P J., Kratz K M., Karnes J L. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993 43 4 817-824 (Pubitemid 23121981)
39. Dyck P J., Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1996 55 12 1181-1193 (Pubitemid 26397137)
40. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995 122 8 561-568
41. Kelly J J. Jr, Kyle R A., O'Brien P C., Dyck P J. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981 31 11 1480-1483 (Pubitemid 12228290)
42. Latov N, Braun P E., Gross R B., Sherman W H., Penn A S., Chess L. Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins. Proc Natl Acad Sci U S A 1981 78 11 7139-7142
43. Latov N, Hays A P., Sherman W H. Peripheral neuropathy and anti-MAG antibodies. Crit Rev Neurobiol 1988 3 4 301-332
44. Comi G, Roveri L, Swan A et al, Inflammatory Neuropathy Cause and Treatment Group. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 2002 249 10 1370-1377 (Pubitemid 35217657)
45. Dalakas M C., Quarles R H., Farrer R G. et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996 40 5 792-795 (Pubitemid 26415192)
46. Dyck P J., Low P A., Windebank A J. et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991 325 21 1482-1486
47. Ernerudh J H., Vrethem M, Andersen O, Lindberg C, Berlin G. Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy. J Neurol Neurosurg Psychiatry 1992 55 10 930-934
48. Mariette X, Chastang C, Clavelou P, Louboutin J P., Leger J M., Brouet J C. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry 1997 63 1 28-34 (Pubitemid 27317357)
49. Nobile-Orazio E, Baldini L, Barbieri S et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 1988 24 1 93-97
50. Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000 123 Pt 4 710-717 (Pubitemid 30162720)
51. Lewis R A. Chronic inflammatory demyelinating polyneuropathy. Neurol Clin 2007 25 1 71-87 (Pubitemid 46283311)
52. Ruts L, Drenthen J, Jacobs B C., van Doorn P A., Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010 74 21 1680-1686
53. Hahn A F., Bolton C F., Zochodne D, Feasby T E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996 119 Pt 4 1067-1077 (Pubitemid 26300709)
54. Dyck P J., Litchy W J., Kratz K M. et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994 36 6 838-845 (Pubitemid 24370922)
55. Katz U, Achiron A, Sherer Y, Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 2007 6 4 257-259 (Pubitemid 46274552)
56. Brannagan T H. III. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology 2002 59 12, Suppl 6 S33-S40
57. Klein C J. The inherited neuropathies. Neurol Clin 2007 25 1 173-207 (Pubitemid 46283314)
58. Benson M D., Kincaid J C. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007 36 4 411-423 (Pubitemid 47512065)
59. Wierzbicki A S., Lloyd M D., Schofield C J., Feher M D., Gibberd F B. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem 2002 80 5 727-735 (Pubitemid 34809224)
60. Pollock M, Nukada H, Frith R W., Simcock J P., Allpress S. Peripheral neuropathy in Tangier disease. Brain 1983 106 Pt 4 911-928 (Pubitemid 14245090)
61. Schiffmann R. Fabry disease. Pharmacol Ther 2009 122 1 65-77
62. Albers J W., Fink J K. Porphyric neuropathy. Muscle Nerve 2004 30 4 410-422 (Pubitemid 39288143)
63. Hansen L M., Kristensen O, Friis M L. [Neuropathy in adult metachromatic leukodystrophy]. Ugeskr Laeger 1994 156 15 2252-2253
64. Marks H G., Scavina M T., Kolodny E H., Palmieri M, Childs J. Krabbe's disease presenting as a peripheral neuropathy. Muscle Nerve 1997 20 8 1024-1028 (Pubitemid 27306515)
65. van Geel B M., Assies J, Wanders R J., Barth P G. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 1997 63 1 4-14 (Pubitemid 27317353)
66. Walker R H., Jung H H., Dobson-Stone C et al. Neurologic phenotypes associated with acanthocytosis. Neurology 2007 68 2 92-98 (Pubitemid 46071891)
67. Di Donato S. Multisystem manifestations of mitochondrial disorders. J Neurol 2009 256 5 693-710
68. Bennett C L., Lawson V H., Brickell K L. et al. Late-onset hereditary axonal neuropathies. Neurology 2008 71 1 14-20
69. England J D., Gronseth G S., Franklin G et al, American Academy of Neurology American Association of Neuromuscular and Electrodiagnostic Medicine American Academy of Physical Medicine and Rehabilitation. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PMR 2009 1 1 5-13
70. Goldstein D J., Lu Y, Detke M J., Lee T C., Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005 116 1-2 109-118 (Pubitemid 40828506)
71. Raskin J, Pritchett Y L., Wang F et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005 6 5 346-356 (Pubitemid 41727332)
72. Lesser H, Sharma U, LaMoreaux L, Poole R M. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004 63 11 2104-2110 (Pubitemid 39636259)
73. Richter R W., Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp L E. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005 6 4 253-260 (Pubitemid 40488803)
74. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004 110 3 628-638 (Pubitemid 39036794)